Mesenchymal stem cell-based treatment for microvascular and secondary complications of diabetes mellitus

GC Davey, SB Patil, A O'Loughlin… - Frontiers in …, 2014 - frontiersin.org
The worldwide increase in the prevalence of Diabetes mellitus (DM) has highlighted the
need for increased research efforts into treatment options for both the disease itself and its …

A fault-tolerant neural network architecture

T Liu, W Wen, L Jiang, Y Wang, C Yang… - Proceedings of the 56th …, 2019 - dl.acm.org
New DNN accelerators based on emerging technologies, such as resistive random access
memory (ReRAM), are gaining increasing research attention given their potential of" in-situ" …

Anti-Inflammatory Mesenchymal Stem Cells (MSC2) Attenuate Symptoms of Painful Diabetic Peripheral Neuropathy

RS Waterman, J Morgenweck… - Stem Cells …, 2012 - academic.oup.com
Mesenchymal stem cells (MSCs) are very attractive candidates in cell-based strategies that
target inflammatory diseases. Preclinical animal studies and many clinical trials have …

[HTML][HTML] Stem cells for the treatment of musculoskeletal pain

L Labusca, F Zugun-Eloae… - World journal of stem …, 2015 - ncbi.nlm.nih.gov
Musculoskeletal-related pain is one of the most disabling health conditions affecting more
than one third of the adult population worldwide. Pain from various mechanisms and origins …

Analgesia for neuropathic pain by dorsal root ganglion transplantation of genetically engineered mesenchymal stem cells: initial results

H Yu, G Fischer, AD Ebert, HE Wu, X Bai… - Molecular …, 2015 - journals.sagepub.com
Background Cell-based therapy may hold promise for treatment of chronic pain.
Mesenchymal stem cells (MSCs) are readily available and robust, and their secretion of …

Клеточная терапия критической ишемии нижних конечностей (проблемы и перспективы)

СВ Лебедев, АВ Карасев, ВВ Кунгурцев… - Вестник Российской …, 2013 - cyberleninka.ru
Критическая ишемия нижних конечностей—синдром ряда различных по этиологии и
патогенезу заболеваний периферических артерий. Критическая ишемия нижних …

Autologous bone marrow–derived cells for venous leg ulcers treatment: a pilot study

G Otero, C Agorio, A Sujanov, L Echarte… - Cytotherapy, 2019 - Elsevier
Background Chronic venous leg ulcers (VLUs) are a common problem in clinical practice
and available treatments are not satisfactory. The use of adjuvant therapies in combination …

Cell therapy of critical limb ischemia (problems and prospects)

SV Lebedev, AV Karasev… - Annals of the …, 2013 - vestnikramn.spr-journal.ru
Critical limb ischemia is a syndrome that combines several peripheral artery diseases with
different ethiology and pathogenesis but with similar prognosis, high morbidity and mortality …

[PDF][PDF] Стимуляция ангиогенеза клетками костного мозга при экспериментальной ишемии конечности

БС Суковатых, АЮ Орлова - Ангиология и сосудистая …, 2017 - fulltext.kurskmed.com
ВВЕДЕНИЕ Критическая ишемия нижних конечностей по материалам
Трансатлантического международного согласительного документа (ТАУС) возникает у …

Фармакологическое лечение экспериментальной критической ишемии конечностей

БС Суковатых, ЕБ Артюшкова, АЮ Орлова… - Человек и его …, 2017 - cyberleninka.ru
Экспериментальным путем на 130 белых крысах-самцах линии Вистар изучена
эффективность миелопида, актовегина и солкосерила в лечении критической ишемии …